This document is high-level guidance and presents the recommendations of the Global IDMP Working Group (GIDWG) for business rules on assigning Pharmaceutical Product Identifiers (PhPIDs) to marketed medicinal products for human use. This document is a work in progress and is regularly updated as the projects advance.